» Articles » PMID: 34130526

Long-term Inhibition of UCHL1 Decreases Hypertension and Retinopathy in Spontaneously Hypertensive Rats

Overview
Journal J Int Med Res
Publisher Sage Publications
Specialty General Medicine
Date 2021 Jun 16
PMID 34130526
Citations 1
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: To investigate the role of the deubiquitinase ubiquitin C-terminal hydrolase L1 (UCHL1) in hypertension and retinopathy in the spontaneously hypertensive rat (SHR).

Methods: Wistar-Kyoto (WKY) rats and SHRs were administered the UCHL1 inhibitor LDN57444 (20 μg/kg/day) for 4 months. Pathological changes were detected with hematoxylin and eosin, immunofluorescence, and dihydroethidium staining. The mRNA and protein expression of UCHL1 were examined by real-time PCR and immunoblotting analysis.

Results: At 6 months of age, SHRs showed significantly increased mRNA and protein levels of UCHL1 in the retina compared with WKY rats. Moreover, SHRs exhibited significantly increased central retinal thickness, inflammation, and reactive oxygen species production compared with WKY rats, and these effects were markedly attenuated by systemic administration of the UCHL1 inhibitor LDN57444. The beneficial effects of LDN57444 were possibly associated with reduced blood pressure and the inactivation of several signaling pathways.

Conclusion: UCHL1 is involved in hypertension and retinopathy in SHRs, suggesting that UCHL1 may be used as a potential therapeutic target for treating hypertensive retinopathy.

Citing Articles

A novel proteomic signature of osteoclast differentiation unveils the deubiquitinase UCHL1 as a necessary osteoclastogenic driver.

Materozzi M, Resnati M, Facchi C, Trudu M, Orfanelli U, Perini T Sci Rep. 2024; 14(1):7290.

PMID: 38538704 PMC: 10973525. DOI: 10.1038/s41598-024-57898-y.

References
1.
Bi H, Zhang Y, Yang J, Shu Q, Yang X, Yan X . Inhibition of UCHL1 by LDN-57444 attenuates Ang II-Induced atrial fibrillation in mice. Hypertens Res. 2019; 43(3):168-177. PMC: 8075865. DOI: 10.1038/s41440-019-0354-z. View

2.
Pohl C, Dikic I . Cellular quality control by the ubiquitin-proteasome system and autophagy. Science. 2019; 366(6467):818-822. DOI: 10.1126/science.aax3769. View

3.
Wong T, Wong T, Mitchell P . The eye in hypertension. Lancet. 2007; 369(9559):425-35. DOI: 10.1016/S0140-6736(07)60198-6. View

4.
Herrmann H, Fiedler U, Blodner R . Pathogenesis of myocardial fibrosis in spontaneously hypertensive rats (SHR). Eur Heart J. 1995; 16(2):243-52. DOI: 10.1093/oxfordjournals.eurheartj.a060891. View

5.
Ying X, Zhao Y, Yao T, Yuan A, Xu L, Gao L . Novel Protective Role for Ubiquitin-Specific Protease 18 in Pathological Cardiac Remodeling. Hypertension. 2016; 68(5):1160-1170. DOI: 10.1161/HYPERTENSIONAHA.116.07562. View